Philips Launches Advanced 3D Imaging Navigation Platform for Faster Lung Cancer Diagnosis

advanced 3D imaging and navigation platform
advanced 3D imaging and navigation platform

What You Should Know:

– Philips paves the way for faster lung cancer diagnosis and treatment with advanced 3D imaging and navigation platform with the launch of Azurion Lung Edition.

– By speeding diagnosis and treatment, Azurion Lung Edition
is helping to transform lung cancer care, contributing to dramatically improved
outcomes and reduced costs.


Royal Philips, today
announced the launch of Azurion
Lung Edition
, an advanced 3D imaging and navigation platform to accelerate
the diagnosis and treatment of lung cancer. The suite combines CT-like 3D
images acquired at the tableside (Cone Beam CT) with live X-ray guidance and
advanced tools to support image-guided lung procedures. The system is designed
specifically for bronchoscopy procedures, enabling clinicians to perform both
minimally invasive endobronchial biopsies and lesion ablation during the same
procedure. By speeding diagnosis and treatment, Azurion Lung Edition is helping
to transform lung cancer care, contributing to dramatically improved outcomes
and reduced costs.

Intuitive, integrated, and efficient, the Azurion platform optimizes clinical and operational lab performance and expands the role of image-guided interventions in the treatment of patients. The platform has achieved rapid global adoption and has been used in well over two million procedures worldwide.

Why It Matters

Each year 1.7 million people
die worldwide of lung cancer, making it the leading cause of cancer deaths
globally and accounting for more loss of life than breast, colon and prostate
cancer combined. Today, over 60% of patients are diagnosed at a late stage,
with a small chance of a surgical cure. But thanks to a rise in the number of
lung cancer screening programs and increasing patient awareness, a growing
proportion of patients have small peripheral lesions that are operable.

In
addition to early diagnosis, fast treatment is critical to ensure better
outcomes and quality of life for lung cancer patients, with every week of delay
resulting in a 5% increase in mortality. Today, most patients face a long
journey to a definitive diagnosis and they often undergo a painful recovery
after open surgery. Cone Beam CT is seen as the gold standard for clinicians to
both diagnose and treat lung cancer in one room, and even during the same
procedure. 

“Image-guided minimally invasive procedures continue to expand into new treatment areas, enabled by sophisticated, procedure-oriented solutions like Azurion Lung Edition,” said Dr. Gupta. “With lung cancer increasingly being detected at an earlier stage, new minimally invasive treatment strategies like ablation have the potential to significantly improve outcomes for patients.”

Availability

Philips Azurion Lung Edition is
available now in the U.S.

<!–

–>